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Summary
 
Nonobese diabetic (NOD) mouse thymocytes are hyporesponsive to T cell antigen receptor
(TCR)-mediated stimulation of proliferation, and this T cell hyporesponsiveness may be causal
to the onset of autoimmune diabetes in NOD mice. We previously showed that TCR-induced
NOD T cell hyporesponsiveness is associated with a block in Ras activation and defective sig-
naling along the PKC/Ras/MAPK pathway. Here, we report that several sequential changes in
TCR-proximal signaling events may mediate this block in Ras activation. We demonstrate
that NOD T cell hyporesponsiveness is associated with the (
 
a
 
) enhanced TCR-
 
b
 
–associated
Fyn kinase activity and the differential activation of the Fyn–TCR-
 
z
 
–Cbl pathway, which may
account for the impaired recruitment of ZAP70 to membrane-bound TCR-
 
z
 
; (
 
b
 
) relative in-
ability of the murine son of sevenless (mSOS) Ras GDP releasing factor activity to translocate
from the cytoplasm to the plasma membrane; and (
 
c
 
) exclusion of mSOS and PLC-
 
g
 
1 from the
TCR-
 
z
 
–associated Grb2/pp36–38/ZAP70 signaling complex. Our data suggest that altered ty-
rosine phosphorylation and targeting of the Grb2/pp36–38/ZAP70 complex to the plasma
membrane and cytoskeleton and the deficient association of mSOS with this Grb2-containing
complex may block the downstream activation of Ras and Ras-mediated amplification of
TCR/CD3-mediated signals in hyporesponsive NOD T cells. These findings implicate mSOS
as an important mediator of downregulation of Ras signaling in hyporesponsive NOD T cells.
 
T
 
he acquisition of immunological self-tolerance is me-
diated by several mechanisms, including the anergy or
proliferative hyporesponsiveness of autoreactive T cells in
response to stimulation through the TCR (1). How this
hyporesponsiveness is achieved and its physiological rele-
vance to the induction of tolerance and autoimmune dis-
ease are incompletely understood. We have focused on the
role of T cell hyporesponsiveness in the induction of insu-
lin-dependent diabetes mellitus (IDDM)
 
1
 
 in nonobese dia-
betic (NOD) mice (2, 3). IDDM results from the breakdown
of self-tolerance and aberrant expansion of autoreactive T
cells in the periphery, which mediate the destruction of pan-
creatic islet 
 
b
 
 cells. In NOD mice, a high proportion of
such autoreactive T cells may not be deleted intrathymi-
cally due to their hyporesponsiveness upon TCR stimula-
tion and/or deficiencies in the differentiation and function
of interacting APCs. Such APC deficiencies may preclude
the stimulation of autoreactive T cells to a sufficiently high
threshold level to induce their deletion (4, 5). As a result,
these T cells may be rendered hyporesponsive to subse-
quent TCR stimulation. Indeed, we previously demon-
strated that NOD thymocytes and peripheral T cells display
a proliferative hyporesponsiveness upon TCR stimulation
(3, 6), which is mediated by their deficient production of
IL-2 and IL-4 (7). Exogenous IL-4 completely restores
NOD T cell proliferative responsiveness in vitro, and the in
vivo administration of IL-4 to NOD mice protects them
against insulitis and IDDM (7).
These observations suggest that T cell hyporesponsive-
 
1
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ness may be causal to the onset of IDDM, and stimulated us
to investigate the biochemical mechanisms of induction of
NOD T cell hyporesponsiveness. We found that Ras acti-
vation is deficient in quiescent and TCR-stimulated NOD
thymocytes, and that this deficiency does not result from
either a decreased amount or activity of the Ras GTPase
activating protein p120 Ras.GAP, a negative regulator of
Ras activation (8). Our findings demonstrated that T cell
hyporesponsiveness is linked to a block in Ras activation in
vivo. Reduced Ras activity was also shown to correlate
with the reduced activity and tyrosine phosphorylation of
the mitogen-activated protein kinase (MAPK) in NOD thy-
mocytes (8). Since MAPK activity is required for progression
to S phase of the cell cycle, reduced tyrosine phosphoryla-
tion of MAPK may abrogate its activity in TCR-stimulated
NOD T cells and elicit their proliferative hyporesponsiveness
(8). Deficient Ras activation and altered MAPK and Jnk pro-
tein kinase activities were also recently observed in anergic
murine CD4
 
1
 
 T cells (9, 10).
After TCR engagement by MHC-bound peptides, Ras
activation is positively regulated by a protein tyrosine ki-
nase (PTK)-dependent signaling pathway that elicits T cell
differentiation and proliferation (11, 12). The phosphoty-
rosine (p-Tyr)-dependent recruitment of GDP releasing
factors (GRFs) to the membrane and the assembly of Ras–
GRF complexes are essential for Ras activation. GRFs acti-
vate Ras by promoting the conversion of GDP-bound Ras
to the active GTP-bound state (13, 14). Murine son of sev-
enless (mSOS) is a GRF that positively activates Ras in T
cells (15, 16). The adaptor protein Grb2 recruits and trans-
locates mSOS to the plasma membrane (16, 17), which
leads to Ras-mediated signaling even in the absence of
TCR stimulation (18). Ras activation may also be indi-
rectly controlled by phospholipase C (PLC)-
 
g
 
1 (19, 20),
after PLC-
 
g
 
1 is activated and translocated to the plasma
membrane after its tyrosine phosphorylation (20).
Translocation of mSOS is dependent on the Lck and Fyn
PTK-mediated tyrosine phosphorylation of TCR-associ-
ated CD3 subunits, which form docking sites for the bind-
ing of secondary signaling proteins containing Src homol-
ogy 2 (SH2) domains (e.g., Grb2) and recruit the ZAP70
cytoplasmic PTK to the TCR–CD3 complex (21–25). In
TCR-activated cells, Grb2 also forms a complex with a
36–38-kD tyrosine phosphoprotein, pp36–38 (26–28), an-
other docking site for SH2 domain–containing proteins.
The PTK-dependent pathway of TCR activation, which
induces the association of mSOS, ZAP70, PLC-
 
g
 
1, and
other phosphoproteins with Grb2 and 
 
z
 
-chain of the TCR
complex (28), is essential for Ras activation.
In this study, we further investigated the mechanism of
inhibition of Ras activation in TCR-stimulated hypore-
sponsive NOD thymocytes. We show that in NOD thy-
mocytes the differential activation of the Fyn–TCR-
 
z
 
–Cbl
pathway may account for the impaired recruitment of
ZAP70 to membrane-bound TCR-
 
z
 
. We also demonstrate
a significant reduction in mSOS GRF activity in TCR-
stimulated NOD thymocytes, which is mediated by the in-
ability of mSOS to be translocated in association with Grb2
to the plasma membrane. Our findings implicate mSOS as
an important mediator of downregulation of TCR-medi-
ated Ras signaling in hyporesponsive NOD thymocytes.
 
Materials and Methods
 
Mice.
 
Female NOD/Del as well as control C57BL/6J and
BALB/cJ (insulitis-free and diabetes-resistant) mice were either
bred in our specific pathogen free animal facility at The John P.
Robarts Research Institute colony or were purchased from The
Jackson Laboratory (Bar Harbor, ME), and were used at 6–8 wk
of age. C57BL/6J and BALB/cJ were chosen as control strains,
since we previously showed that C57BL/6J and BALB/cJ thy-
mocytes proliferate normally in response to TCR stimulation of
proliferation in vitro (3, 5).
 
Antibodies and Glutathione S-transferase (GST) Fusion Proteins.
 
The mAbs used were the following: biotin-conjugated hamster
H57-597 anti–TCR-
 
b
 
 and rat L3T4 anti-CD4 (PharMingen,
San Diego, CA); rat IgG1 anti–H-Ras, mouse anti-Lck, mouse
anti–TCR-
 
z
 
 (6B10.2), and mouse PY20 (IgG2b) anti–p-Tyr
(Santa Cruz Biotechnology, Santa Cruz, CA); mouse anti-Grb2,
mouse anti-mSOS1, and mouse anti-mZAP70 (Transduction
Laboratory, Lexington, KY). Mouse anti-Fyn and anti–TCR-
 
z
 
mAbs and a polyclonal anti-ZAP70 antiserum were gifts from Dr.
J. Bolen (Bristol-Myers Squibb, Princeton, NJ). The following
polyclonal rabbit Abs were supplied by Santa Cruz Biotechnol-
ogy: anti-mSOS 1/2, anti-Grb2, anti-Cbl, and anti–PLC-
 
g
 
1C.
The polyclonal rabbit anti–mouse Lck and anti–mouse Fyn Abs
were provided by Dr. A. Veillette (McGill University, Montreal,
Quebec, Canada). Rabbit polyclonal anti–TCR-
 
z
 
 serum 387 was
obtained from Dr. L. Samelson (National Institutes of Health,
Bethesda, MD). GST murine Grb2–SH2 domain fusion protein
(GST–Grb2–SH2) was provided by Drs. D. Motto and G. Ko-
retsky (University of Iowa, Iowa City, IA).
 
Cell Activation and Lysis.
 
NOD, C57BL/6J, and BALB/cJ
thymocytes or peripheral splenic T cells purified on murine T cell
enrichment columns (R&D Systems, Minneapolis, MN) (purity
 
.
 
95%) were maintained on ice in DMEM supplemented with 20
mM Hepes (all GIBCO BRL, Burlington, Ontario, Canada) until
stimulation. The total number of thymocytes and percent distri-
bution of CD4
 
1
 
CD8
 
1
 
 double-positive and CD4
 
1
 
 and CD8
 
1
 
single-positive thymocytes are very similar in NOD and C57BL/
6J control mice (3). This ensures that the differences observed do
not reflect an unappreciated change in thymocyte composition in
these mouse strains. Where not otherwise indicated, quiescent
thymocytes or T cells (4 
 
3
 
 10
 
7
 
/ml) were stimulated (3 min at
37
 
8
 
C) with 1 
 
m
 
g/10
 
7
 
 cells of the biotin-conjugated H57-597
hamster anti–mouse TCR-
 
b
 
 mAb either alone or together with
the biotin-conjugated rat anti–mouse CD4 L3T4 mAb. Cross-
linking of mAbs was accomplished using streptavidin or protein
G (Sigma Chemical Co., St. Louis, MO) for various times at a 4:1
wt/wt ratio. Cells were lysed in ice-cold 50 mM Tris, pH 8.0,
150 mM NaCl, 5 mM EGTA lysis buffer containing 1% Brij 97
or Triton X-100, 0.2% NP-40, 5% glycerol, and supplemented
with a mixture of protease and phosphatase inhibitors (100 
 
m
 
M
 
p
 
-nitrophenyl guanidinobenzoate, 1 mM PMSF, 10 
 
m
 
g/ml apro-
tinin, 10 
 
m
 
g/ml leupeptin, 5 
 
m
 
g/ml pepstatin, 2 mM Na
 
3
 
VO
 
4
 
, 10
mM Na
 
2
 
PO
 
4
 
, and 10 mM NaF) (all obtained from Sigma Chem-
ical Co.). Alternatively, RIPA buffer (20 mM Tris, pH 8.0, 0.15
M NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 1% NP-40,
0.5% Na deoxycholate, plus above mixture of protease and phos-
phatase inhibitors) was used to lyse cells and immunoprecipitate 
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Fyn and Cbl in Fig. 5. All subsequent steps were performed at
4
 
8
 
C. Lysates were clarified of detergent-insoluble material by
centrifugation (10 min, 14,000 rpm), precleared with protein
A–Sepharose CL-4B (Pharmacia Biotech, Inc., Baie d’Urfe, Que-
bec,  Canada), and 50-
 
m
 
l aliquots were quantitated for their
amounts of protein by the Bradford assay using BSA as standard.
 
Subcellular Fractionation.
 
Cells (10
 
8
 
) were resuspended and lysed
by brief sonication in ice-cold 10 mM Tris, pH 7.4, 10 mM KCl,
1.5 mM MgCl
 
2
 
, 2 mM EGTA hypotonic buffer containing the
above-described mixture of protease and phosphatase inhibitors
(buffer A). Lysates were adjusted to 150 mM NaCl, centrifuged
to remove nuclei and debris, and particulate membrane-contain-
ing (P100) and soluble cytoplasm-containing (S100) fractions
were separated by differential centrifugation for 30 min at
100,000 
 
g
 
 (25). Membrane fractions were washed with ice-cold
buffer A and solubilized by sonication in buffer A supplemented
with 150 mM NaCl and 1% Triton X-100. After recentrifugation
(10 min, 100,000 
 
g
 
), the detergent-insoluble cytoskeleton-con-
taining fraction was extracted with RIPA buffer and recentri-
fuged.
 
Immunoprecipitations and Affinity Precipitations of Cellular Pro-
teins.
 
Precleared postnuclear fractions obtained from 2–4 
 
3
 
 10
 
7
 
cells were normalized for protein concentration levels and immu-
noprecipitated (3 h at 4
 
8
 
C) with the specific polyclonal Abs or
control isotype-matched preimmune Ig precoupled to 25 
 
m
 
l of
protein A–Sepharose CL-4B, protein A/G agarose (Santa Cruz
Biotechnology) or streptavidin immobilized on 4% beaded aga-
rose (Sigma Chemical Co.). This was followed by four washes of
the precipitates with ice-cold lysis buffer. For affinity precipita-
tions, GST fusion proteins (10 
 
m
 
g) or control GST (10 
 
m
 
g) non-
covalently coupled to glutathione–agarose beads were reacted (2 h
at 4
 
8
 
C) with cell lysates and washed extensively in lysis buffer.
 
Gel Electrophoresis and Immunoblotting.
 
Precipitated proteins
were solubilized in 2
 
3
 
 Laemmli sample buffer containing 2-ME,
20 mM EDTA, and 2 mM Na
 
3
 
VO
 
4
 
, resolved by SDS-PAGE
(8–16% gradient gel; Novex, San Diego, CA) under reducing
conditions, transferred to Immobilon (Millipore, Bedford, MA) or
nitrocellulose (Schleicher & Schuell, Keene, NH) membranes, and
immunoblotted with the indicated Abs. Blots were developed by
enhanced chemiluminescence (Amersham Life Science, Inc., Ar-
lington Heights, IL). Signal intensities were quantified using a
Molecular Imager System and Molecular Analyst imaging soft-
ware (Bio-Rad, Hercules, CA). Immunoblots revealed that qui-
escent NOD and control thymocytes contain equivalent amounts
of the TCR-
 
z
 
, CD3
 
e
 
, ZAP70, Syk, Fyn, Lck, Grb2, Cbl,
mSOS1, PLC-
 
g
 
1, and phosphatidylinositol 3-kinase (p85 sub-
unit) proteins.
 
In Vitro Kinase Assay.
 
Precipitated proteins (2 
 
3
 
 10
 
7
 
 T cell
equivalents/sample) were assayed for associated in vitro kinase ac-
tivity after washing the beads in kinase buffer (25 mM Hepes, pH
7.4, 5 mM MnCl
 
2
 
) containing 0.1% NP-40 and incubation (15
min at 20
 
8
 
C) with either [
 
g
 
-
 
32
 
P]ATP (10 
 
m
 
Ci; New England
Nuclear, Boston, MA) or 500 
 
m
 
M cold ATP in 25 
 
m
 
l kinase
buffer containing 0.1% NP-40. Reactions were stopped by addi-
tion of an ice-cold buffer containing 50 mM Tris, pH 8.0, 150
mM NaCl, 5 mM MnCl
 
2
 
, 20 mM EDTA, 0.2% NP-40, and 10
mM NaF. Proteins were resolved by SDS-PAGE as described
above, transferred to Immobilon membranes, and treated (1 h at
55
 
8
 
C) with 1 M KOH to remove alkali–labile phosphate groups
from threonine- and serine-phosphorylated proteins (29). Mem-
branes were immunoblotted serially, and overlay of autoradio-
grams confirmed the nature of the phosphoproteins.
 
32
 
P-Labeling and Peptide Mapping of Fyn.
 
Cells were incubated
for 2 h in phosphate-free DMEM supplemented with 2% dia-
lyzed FCS and 20 mM Hepes, pH 7.3, containing 0.5 mCi/ml of
carrier-free ortho[
 
32
 
P]phosphate (New England Nuclear), washed
with phosphate-free DMEM, and lysed. Immunoprecipitated
 
32
 
P-labeled Fyn was resolved by SDS-PAGE, transferred onto a
nitrocellulose membrane and cleaved by cyanogen bromide (50–
100 mg/ml) (Sigma Chemical Co.) for 1 h in 70% (vol/vol) for-
mic acid (30). 
 
32
 
P-labeled Fyn fragments were resolved by SDS-
PAGE (24% gel) in a Tricine cathode buffer, and autoradiograph
signal intensities were quantified.
 
Ras GDP Releasing Activity Assay.
 
mSOS was immunopre-
cipitated from the detergent-soluble membrane fraction with
polyclonal rabbit anti-mSOS Abs, and in vitro c-Ha–Ras–GDP
releasing activity was measured by a nitrocellulose filter binding
assay (31). In brief, c-Ha–Ras protein (2.5 pmol/sample; Sigma
Chemical Co.) was incubated (60 min at 32
 
8
 
C) with [8-
 
3
 
H]5
 
9
 
-
GDP (25 pmol/sample, 1.0 mCi/ml; Amersham Life Science,
Inc.) in exchange buffer (20 mM Tris–HCl, pH 7.5, 100 mM
NaCl, 1 mM MgCl
 
2
 
, 1 mM dithiothreitol, and 40 
 
m
 
g/ml BSA).
mSOS immune complexes bound to protein A–Sepharose CL-
4B were washed five times with exchange buffer, and reactions
(performed in duplicate) were started by addition of [8-
 
3
 
H]5
 
9
 
-
GDP–c-Ha–Ras complexes in exchange buffer containing nonra-
dioactive GTP (500 
 
m
 
M). Immunoprecipitates containing GDP
releasing activity were shaken (30 min at 30
 
8
 
C), centrifuged, and
supernatants were filtered through nitrocellulose (0.2 
 
m
 
m BA85
membranes; Schleicher & Schuell). Membranes were washed
with ice-cold 20 mM Tris–HCl, pH 7.5, 100 mM NaCl, and 10
mM MgCl
 
2
 
, and membrane-bound radioactivity was quantitated
using a liquid scintillation counter.
 
Results
 
Ras GRF Activity Is Deficient in TCR-stimulated NOD
Thymocytes due to the Inability of mSOS to Translocate to the
Plasma Membrane in Association with Grb2.
 
Upon TCR cross-
linking, SOS generally redistributes to a plasma membrane–
localized Ras and TCR–CD3 complex in association with
Grb2 (25, 26). To investigate whether this type of redistri-
bution occurs in TCR-stimulated NOD thymocytes, we
analyzed the plasma membrane associated mSOS-regulated
Ras GRF activity before and after TCR cross-linking. In
NOD thymocytes, the amount of TCR-induced mSOS-
dependent Ras GDP releasing activity in the membrane-
containing fraction was lower than that observed in control
C57BL/6J thymocytes, and this low level of mSOS GRF
activity was not increased significantly after TCR-b–CD4
co–cross-linking (Fig. 1 A). Anti-mSOS mAb immuno-
blotting performed after normalization for protein concen-
tration levels, and the approximately equivalent amounts of
constitutively membrane-associated Ras protein observed
in each sample revealed that relatively small amounts of
mSOS associate with the plasma membrane in NOD and
control thymocytes in the absence of TCR-b ligation (Fig.
1 B). Whereas TCR-b and TCR-b–CD4 cross-linking in-
duced the recruitment of mSOS to the plasma membrane
in control C57BL/6J and BALB/cJ thymocytes, this re-
cruitment was markedly decreased in activated NOD thy-
mocytes. Since Ras deficiency in TCR-stimulated hypore-
sponsive NOD thymocytes does not result from altered890 Altered TCR–CD3 Phosphorylation and mSOS Activity in NOD T Cells
amounts or activity of p120 Ras.GAP (8), deficient mSOS-
associated Ras GRF activity and impaired recruitment of
mSOS to the plasma membrane may account for the de-
crease in Ras activation observed here.
To investigate whether deficient Ras activation is caused
by the inability of Grb2 to translocate to the plasma mem-
brane and/or its incapacity to recruit mSOS and PLC-g1C
into TCR signaling complexes, we determined the relative
amounts of Grb2 in cytoplasmic and membrane fractions of
NOD and control thymocytes. Immunoblotting of Grb2
immunoprecipitates from membrane fractions with anti-
Grb2, anti-SOS, and anti–PLC-g1C Abs demonstrated
that at 1.5 min after TCR-b and TCR-b–CD4 cross-link-
ing, the amounts of Grb2 and Grb2-associated mSOS and
PLC-g1C translocated to the plasma membrane were
lower in NOD thymocytes than control thymocytes (Fig. 1
C). Moreover, TCR-b and TCR-b–CD4 cross-linking
induced marked increases in the membrane/cytoplasmic
ratio for Grb2 and Grb2-associated mSOS and PLC-g1C
only in control strain thymocytes. The membrane/cyto-
plasmic ratios observed reflect the amounts of Grb2,
mSOS, and PLC-g1C translocated from the cytoplasm to
Figure 1. NOD thymocytes exhibit a constitutive reduction in mSOS activity due to its inability to be translocated from the cytoplasm to the plasma
membrane. (A) mSOS was immunoprecipitated from the membrane fractions of NOD and B6 thymocytes (108 cells/lane) previously stimulated for 1.5
min by anti–TCR-b or anti–TCR-b plus anti-CD4. Ras GDP releasing activity associated with these immunoprecipitates was analyzed in vitro by de-
termining the amount of released [8-3H]59-GDP–Ras radioactivity in a nitrocellulose filter binding assay. Results are expressed as the percentage of
change in mSOS GDP releasing activity relative to the basal level achieved in control samples (none). (B) NOD and control (C57BL/6J [B6] and BALB/
cJ [B/c]) thymocytes were either not stimulated (None) or were stimulated for 1.5 min by anti–TCR-b or anti–TCR-b plus anti-CD4. Immunoblotting
(IB) of thymocyte membrane fractions was performed with anti-mSOS and anti-Ras mAbs. Data are expressed as the relative fold change for the relative
signal intensities calculated as a/b, where a is the specific signal intensity ([density 3 area]/lane) obtained after TCR-b or TCR-b–CD4 cross-linking and
b is the basal signal intensity (B6 control without cross-linking). (C) Membrane translocation of Grb2-bound mSOS and PLC-g1C is reduced in stimu-
lated NOD thymocytes. NOD and control thymocytes were either not stimulated (None) or were stimulated as in B. Immunoblotting of Grb2 immuno-
precipitates (IP) from thymocyte membrane and cytoplasmic fractions was performed with anti-Grb2, anti-mSOS, and anti–PLC-g1C mAbs. Data are
expressed as the membrane/cytoplasmic ratio, calculated as a/b, where a is the relative signal intensity (density 3 area) obtained for corresponding pro-
teins precipitated from the membrane fraction, and b is the same value obtained after precipitation of proteins from the cytoplasmic fraction. The results
shown are representative of one of two separate reproducible experiments.891 Salojin et al.
the plasma membrane in the close vicinity of the TCR sig-
naling complex and its downstream effectors, including
Ras. Thus, the TCR-induced deficiency in Ras GRF ac-
tivity in NOD thymocytes appears to be mediated by the
inability of Grb2 to translocate to the plasma membrane.
The observed differences in the amounts of the Grb2-
mediated recruitment of mSOS and PLC-g1C to the plasma
membrane in NOD and control thymocytes persisted at
longer times (5 and 20 min after TCR-b–CD4 cross-link-
ing) of TCR stimulation, and are not due to differences in
the kinetics of Grb2 recruitment (data not shown). In addi-
tion, we did not observe any plasma membrane transloca-
tion of the Shc phosphoprotein in TCR-stimulated NOD
and C57BL/6J thymocytes (our unpublished observations),
suggesting that Shc may not influence the membrane tar-
geting of SOS in thymocytes.
Altered Tyrosine Phosphorylation and Targeting of the Grb2/
pp36–38/ZAP70 Complex to the Plasma Membrane and Cy-
toskeleton Impair TCR-induced Signaling in NOD Thymocytes.
We investigated whether the TCR-stimulated tyrosine phos-
phorylation and interactions of various docking phospho-
proteins, which associate with Grb2 and recruit mSOS and
PLC-g1C into TCR–Ras signaling complexes, are defi-
cient and contribute to a block in Ras activation in TCR-
stimulated NOD thymocytes. In particular, we examined
whether TCR ligation (a) induces an increase in TCR-
z–ZAP70 association and ZAP70 tyrosine phosphorylation
in the membrane fraction of NOD thymocytes and (b) en-
ables Grb2 and ZAP70 to translocate to the TCR and pro-
mote the membrane targeting of the Grb2–SOS complex.
Immunoblotting of TCR-z immunoprecipitates from the
membrane fraction with anti-ZAP70 and anti-Grb2 Abs
revealed that relatively small amounts of ZAP70 and Grb2
associate with TCR-z in NOD and control thymocytes,
even in the absence of TCR-b ligation (Fig. 2 A). TCR-b
and TCR-b–CD4 cross-linking induced the recruitment
of ZAP70 and Grb2 to the TCR-z–containing complex in
control C57BL/6J and BALB/cJ thymocytes; however,
this recruitment was markedly decreased in activated NOD
thymocytes. Similarly, TCR–CD4-induced tyrosine phos-
phorylation of ZAP70 was reduced considerably in NOD
thymocytes compared with control thymocytes. Both be-
fore and after TCR-b and TCR-b–CD4 cross-linking,
immunoblotting of TCR-z after anti–TCR-z immunopre-
cipitation showed that equal amounts of TCR-z were
present in the membrane fractions of C57BL/6J, BALB/cJ,
and NOD thymocytes.
pp36–38 may mediate the inducible membrane targeting
and recruitment of Grb2–SOS and Grb2–PLC-g1 by bind-
ing to the Grb2 SH2 domain (26–28). To determine if de-
ficient recruitment of Grb2 to the plasma membrane corre-
lates with diminished tyrosine phosphorylation of pp36–38
and decreased binding of Grb2 to pp36–38, phospho-
pp36–38 was affinity precipitated with a GST–Grb2–SH2
fusion protein and immunoblotted with anti–p-Tyr. The
extent of tyrosine phosphorylation of pp36–38 bound to
GST–Grb2–SH2 was significantly reduced in TCR-b– and
TCR-b–CD4-stimulated NOD thymocytes compared with
control thymocytes (Fig. 2 B). Control affinity precipita-
tions with GST alone did not yield any appreciable amount
of bound pp36–38. Immunoprecipitation of mSOS1/2 and
blotting with anti–p-Tyr revealed that while phospho-
pp36–38 was induced to associate with mSOS1/2 in con-
trol C57BL/6J and BALB/cJ thymocytes upon TCR-b
Figure 2. (A) TCR-induced asso-
ciation of TCR-z with ZAP70 and
Grb2 in the plasma membrane and
tyrosine phosphorylation of ZAP70
is markedly decreased in NOD thy-
mocytes. NOD and control thy-
mocytes were either unstimulated
(None) or stimulated for 1.5 min with
anti–TCR-b or anti–TCR-b plus
anti-CD4. TCR-z was immunopre-
cipitated from thymocyte membrane
fractions (108 cell equivalents/sam-
ple), and immunoprecipitates were
immunoblotted with either anti-
ZAP70, anti-Grb2, anti–p-Tyr, or
anti–TCR-z Abs. The latter anti–
TCR-z immunoblots showed that
equal amounts of TCR-z were pre-
cipitated from these thymocyte
membrane fractions before and after
TCR-b and TCR-b–CD4 cross-
linking. (B) Affinity precipitation of
phospho-pp36–38 from the mem-
brane fractions of TCR-b– and
TCR-b–CD4-stimulated NOD and control thymocytes with the GST–Grb2–SH2 fusion protein (lanes 1–9) and GST alone (lane 10) immobilized on
glutathione–agarose beads. Precipitated proteins were immunoblotted with anti–p-Tyr. (C) Tyrosine phosphorylation of pp36–38 bound to mSOS1/2
in NOD thymocytes. NOD and control thymocytes were either unstimulated (None) or stimulated as in A. Equal amounts of mSOS1/2 were immuno-
precipitated from total cell lysates (4 3 107 cell equivalents/sample), and immunoprecipitates were immunoblotted with either anti–p-Tyr or anti-
mSOS1 mAbs. The results shown are representative of one of two separate reproducible experiments.892 Altered TCR–CD3 Phosphorylation and mSOS Activity in NOD T Cells
and TCR-b–CD4 cross-linking, about fourfold less phos-
pho-pp36–38 was bound to mSOS1/2 in stimulated NOD
thymocytes (Fig. 2 C). As Grb2-associated phospho-pp36–38
partitions exclusively in the particulate (membrane) fraction
of cells (26, 27), these results suggest that a decrease in ty-
rosine phosphorylation of pp36–38 is responsible for the
impaired recruitment of the Grb2–SOS complex to the
plasma membrane in TCR-stimulated NOD thymocytes.
TCR ligation can induce the association of tyrosine-
phosphorylated TCR-z chains with a cytoskeleton-enriched
subcellular fraction of T cells, and this cytoskeletal associa-
tion generally correlates with IL-2 production (32). Since
TCR-stimulated NOD splenic T cells are deficient in IL-2
production (7), we tested whether TCR-b–CD4 cross-
linking induces a decrease in the association of TCR-z,
Grb2, and ZAP70 with the cytoskeleton in NOD T cells.
Immunoblotting of proteins in a cytoskeleton-enriched frac-
tion, isolated by differential centrifugation as described
(25), with anti–TCR-z, anti-Grb2, and anti-ZAP70 Abs
confirmed that these proteins are inducibly associated with
the cytoskeleton after TCR-b–CD4 cross-linking in con-
trol BALB/cJ and C57BL/6J splenic T cells (Fig. 3). How-
ever, the cytoskeletal associations of TCR-z, Grb2, and
ZAP70 are reduced considerably in NOD splenic T cells
after coligation of TCR-b and CD4. These results suggest
that the TCR-induced deficiencies in association of TCR-z,
Grb2, and ZAP70 with the cytoskeleton may mediate the
proliferative hyporesponsiveness and reduced IL-2 secre-
tion of NOD T cells.
TCR Ligation Induces Enhanced TCR-b–associated Fyn Ki-
nase Activity in NOD Thymocytes. In anergic CD41 periph-
eral T cells, Fyn activity is elevated (33, 34) and Fyn, but
neither Lck nor ZAP70, associates with TCR-z (29). To
test whether similar events occur in hyporesponsive NOD
thymocytes, the levels and kinetics of TCR-associated Fyn
activity and the relative capacities of Fyn to bind to TCR-z
induced upon TCR ligation were determined. A rapid in-
crease in tyrosine phosphorylation of membrane-localized
Fyn, CD3, and TCR-z was noted (Fig. 4 A). The most
striking difference between NOD and control C57BL/6J
thymocytes was the elevated autophosphorylation of mem-
brane-bound Fyn both in quiescent (no cross-linking) and
TCR-b–stimulated NOD thymocytes. This was accompa-
nied by the transient tyrosine hyperphosphorylation of CD3
and TCR-z. At each time of analysis (0–20 min), slightly
increased amounts of Fyn coprecipitated with TCR-b be-
fore and after cross-linking, indicating that Fyn is constitu-
tively associated with TCR in the membrane. Anti-Lck
and anti-ZAP70 mAb immunoblotting confirmed that in-
creased Fyn activity was not due to the presence of Lck or
ZAP70 in TCR-b immunoprecipitates (data not shown).
A significant increase in basal (no cross-linking) and TCR-b
cross-linking–induced tyrosine phosphorylation of total cel-
lular Fyn was also observed in NOD thymocytes (Fig. 4 B),
and a similar result was obtained using an in vitro kinase as-
say (Fig. 4 C).
To analyze the basis of increased Fyn activity, we inves-
tigated whether Fyn is present in a constitutively active
form in quiescent NOD thymocytes relative to control
thymocytes. The status of phosphorylation of Fyn residue
Tyr528 was determined, as this residue is the site of negative
regulation by the Csk PTK and positive regulation by the
CD45 protein tyrosine phosphatase. Hyperphosphorylation
of Tyr528 inactivates Fyn, whereas a reduction in or absence
of phosphorylation of Tyr528 stimulates Fyn kinase activity.
Cyanogen bromide cleavage of 32P-labeled Fyn and subse-
quent phosphopeptide mapping studies were performed to
distinguish between 32P-labeled peptides resulting from
phosphorylation of Fyn at NH2-terminal sites of phosphor-
ylation and phosphorylation at the Tyr528 autoregulatory
site. In NOD thymocytes, the COOH-terminal Tyr528-
containing Fyn phosphopeptide is phosphorylated only very
weakly relative to the NH2-terminal peptide containing
sites of serine, threonine, and tyrosine phosphorylation,
yielding a NH2/COOH peptide 32P-labeling ratio of 1.7
(Fig. 4 D). In contrast, the levels of phosphorylation of the
COOH-terminal Tyr528-containing Fyn phosphopeptide
and NH2-terminal peptide were essentially equivalent in
C57BL/6J thymocytes, as a NH2/COOH peptide 32P-label-
ing ratio of 0.9 was observed. The relative amounts of
32P-label in the NH2-terminal Fyn phosphopeptides were
about equal in NOD and C57BL/6J thymocytes.
The above-described studies suggest that TCR-associ-
ated Fyn is directly responsible for the observed TCR-
induced increases in its autophosphorylation, based on our
inability to detect Lck and ZAP70 in Fyn immunoprecipi-
tates (our unpublished data). This raised the possibility that
this heightened autophosphorylation and binding of Fyn to
TCR-z may account for the impaired recruitment of
ZAP70 to membrane-bound TCR-z in TCR-stimulated
NOD thymocytes, as noted earlier in Fig. 2 A. To test this
possibility further, we compared the relative amounts of
TCR-z that associate with ZAP70 independently of Fyn as
a result of TCR-b–CD4 cross-linking in NOD and con-
trol thymocytes. A marked increase in Fyn-associated
TCR-z was found in activated NOD thymocytes (Fig. 4
C). When supernatants of these Fyn immunoprecipitates
were precleared of detectable Fyn, then immunoprecipitated
with anti-ZAP70 and immunoblotted with anti–TCR-z,
less ZAP70-associated TCR-z was detected in stimulated
NOD thymocytes. These data support the idea that the in-
Figure 3. TCR-induced cy-
toskeletal associations of TCR-z,
Grb2, and ZAP70 are dimin-
ished in NOD T cells. T cell cy-
toskeleton-enriched fractions
were prepared from NOD and
control splenic T cells (4 3 107
cell equivalents/sample) stimu-
lated by TCR-b or TCR-b–CD4
for 1.5 min at 378C. Cytoskele-
ton-associated proteins were im-
munoblotted with anti–TCR-z,
anti-ZAP70, or anti-Grb2 Abs.
The results shown are represen-
tative of one of three separate re-
producible experiments.893 Salojin et al.
creased binding of TCR-z to TCR-associated Fyn dimin-
ishes the capacity of TCR-z to interact with ZAP70 in the
plasma membrane of TCR-stimulated NOD thymocytes.
TCR Stimulation Induces the Differential Activation of the
Fyn–Cbl Signaling Pathway in NOD Thymocytes. In T cells,
Fyn preferentially interacts with Cbl, and TCR cross-link-
ing–induced tyrosine phosphorylation of Cbl is mediated
by Fyn activity (35, 36). The ability of Cbl to inhibit Syk
PTK activity indicates that Cbl may function as a negative
regulator of intracellular signaling (37). Therefore, we ana-
lyzed whether differential activation of the Fyn signaling
pathway affects the function of Cbl in NOD thymocytes.
TCR-b cross-linking rapidly induced the tyrosine hyper-
phosphorylation of total cellular Cbl in NOD thymocytes
but not control C57BL/6J and Balb/cJ thymocytes (Fig. 5
A). In contrast, upon TCR-b–CD4 cross-linking, this dif-
ference between NOD and control thymocytes was less
pronounced, which indicates that the high levels of ty-
rosine phosphorylation of Cbl induced in control thy-
mocytes might mask the difference observed upon TCR
cross-linking.
The ability of Fyn to phosphorylate Cbl as a substrate
was examined after immunoprecipitation of Cbl from pre-
cleared postnuclear fractions of unstimulated thymocyte ly-
sates. The specificity of the in vitro cold kinase assay was
maintained by using the high stringency RIPA buffer for
cell lysis and immunoprecipitation of Fyn and Cbl. Fyn and
Cbl RIPA immunoprecipitates did not contain associated
kinase activity, based on the detection of Fyn and Cbl but
neither Lck, ZAP70, Syk, nor any additional phosphopro-
teins in these precipitates. Anti–p-Tyr immunoblotting re-
vealed that TCR-b cross-linking in NOD thymocytes rap-
idly (within 1.5 min) enhanced Fyn autophosphorylation
and Fyn-mediated tyrosine phosphorylation of Cbl, which
was significantly higher in NOD than control C57BL/6J
thymocytes (Fig. 5 B). Thus, the Fyn–Cbl signaling path-
way seems to be highly activated in TCR-stimulated NOD
than control thymocytes.
Figure 4. (A) Time course of
activation of TCR-b–associated
kinase activity in TCR-b–stimu-
lated NOD and B6 thymocytes.
NOD and control B6 thy-
mocytes (2 3 107 cells/lane)
were incubated for 3 min in the
presence of biotinylated anti–
TCR-b. Cell-bound mAbs were
either not cross-linked (0 min)
or were cross-linked for the indi-
cated times in the presence of
protein G. Cells were washed to
remove unbound mAbs, and
TCR-b–immune complexes
were immunoprecipitated from
precleared postnuclear fractions
of thymocyte lysates using
streptavidin immobilized on 4%
beaded agarose and then assayed
for their associated in vitro ki-
nase activity. Membranes were
then immunoblotted serially
with different mAbs, and overlay
of autoradiograms and immuno-
blots demonstrated equal load-
ing in each lane (data not shown)
and confirmed the nature of the
proteins phosphorylated in
vitro. The positions of molecular
mass markers are shown on the
left. The results shown are repre-
sentative of one of three separate
reproducible experiments. (B) Tyrosine phosphorylation of Fyn is markedly increased in NOD thymocytes. NOD and control B6 thymocytes (2 3 107
cells/lane) were either unstimulated (None) or stimulated for 1.5 min with anti–TCR-b or anti–TCR-b plus anti-CD4. Fyn was immunoprecipitated
from precleared postnuclear fractions of thymocyte lysates, and immunoprecipitates were immunoblotted with an anti–p-Tyr mAb. (C) Stimulation of
Fyn-associated kinase activity and diminished association of Fyn-independent TCR-z with ZAP70 in response to TCR-b or TCR-b–CD4 treatment of
NOD and B6 thymocytes. NOD and B6 thymocyte lysates were immunoprecipitated with anti-Fyn and assayed for Fyn-associated kinase activity in in
vitro kinase assays. Overlay of autoradiograms and immunoblots demonstrated equal loading in each lane and confirmed the nature of the detected
phosphoproteins (anti-Fyn immunoblotting, data not shown; anti–TCR-z immunoblotting, middle). Supernatants precleared of Fyn were immunopre-
cipitated with anti-ZAP70, and the amounts of residual (Fyn-independent) TCR-z in these precipitates were analyzed by immunoblotting (bottom). (D)
The level of Tyr528 phosphorylation of Fyn is decreased in quiescent NOD thymocytes. [32P]Phosphate labeling and peptide mapping of Fyn immobi-
lized to membrane. [32P]Phosphate-labeled Fyn fragments were resolved by SDS-24% PAGE in a Tricine cathode buffer, and the signal intensities from
autoradiographs were quantified. Results are expressed as the ratio of the signal intensity of the potential NH2-terminal sites of serine, threonine, and ty-
rosine phosphorylation (NH2) relative to the Tyr528-containing regulatory COOH-terminal site (COOH). The results shown are representative of one of
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Discussion
Previously, we found that TCR-induced T cell hypore-
sponsiveness may be causal to the onset of autoimmune di-
abetes in NOD mice (3, 6, 7), and that this hyporespon-
siveness is associated with a block in Ras activation and
altered tyrosine phosphorylation of downstream effectors of
Ras in NOD T cells (8). In this report, we extended our
investigation of the mechanism(s) of TCR-induced hypo-
responsiveness in NOD thymocytes by conducting bio-
chemical analyses of the pathway of downregulation of
TCR-proximal signaling and inhibition of Ras activation.
Our major findings are that NOD T cell hyporesponsive-
ness is mediated by (a) enhanced TCR-b–associated Fyn
activity and the differential activation of the Fyn–TCR-z–
Cbl pathway; (b) deficient translocation of mSOS and
PLC-g1 in association with Grb2 from the cytoplasm to
the plasma membrane; and (c) a reduction in the capacity of
the mSOS GRF to activate Ras and deliver downstream
signals essential for T cell proliferation.
This impaired recruitment of Grb2–mSOS and Grb2–
PLC-g1C complexes to a membrane-localized TCR com-
plex correlates with the diminished abilities of Grb2 and
ZAP70 to interact with TCR-associated pp36–38 and
TCR-z. Accordingly, changes in the tyrosine phosphoryla-
tion of the TCR complex may interfere with the targeting
of these Grb2-containing complexes to membrane-local-
ized Ras, and seem to be key steps in the pathway that lead
to the consequent block in Ras activation in hyporespon-
sive T cells. It is possible that the uncoupling of the Grb2–
mSOS complex from p36–38 and TCR-z may prevent the
derepression of the COOH-terminal autoinhibitory do-
main of mSOS, which normally occurs upon the formation
of a trimeric complex between Grb2, mSOS, and docking
phosphoproteins (38).
In contrast with our observations presented here, the
block in Ras activation in an anergic murine CD41 Th1
clone does not result from either a defect in association be-
tween Shc, Grb2, and mSOS or from a defect in Shc phos-
phorylation (9). The reasons for the discrepancies between
the latter data and ours are presently unclear. However, it is
intriguing to note that, in B cells, Ras activation may be in-
hibited under negative signaling conditions, and that this
block in Ras activity is associated with diminished Shc–
Grb2 interaction and attenuation of the Grb2–mSOS signal
(39). Thus, different signaling mechanisms appear to medi-
ate T cell hyporesponsiveness, dependent on the origin of
the T cells and their state of differentiation and activation.
Nonetheless, a common feature of the different mecha-
nisms of T cell hyporesponsiveness reported is that a block
in Ras activation accompanies the anergic state.
Fyn activity may transduce the signals that mediate T cell
hyporesponsiveness by a mechanism in which TCR-depen-
dent signals originate from the association of Fyn with
TCR-z in the TCR–CD3 complex. In contrast with TCR
ligation in the presence of appropriate costimulation, which
elicits the association of TCR-z with ZAP70, ligation of
TCR by an alloantigen alone stimulates the tyrosine phos-
phorylation of TCR-z and its association with Fyn (29).
The latter Fyn–TCR-z interaction mediates T cell hypore-
sponsiveness. Our analyses of Fyn activity in response to
TCR-b cross-linking demonstrated a relative increase in
both the tyrosine phosphorylation of Fyn and binding of
TCR-associated phospho-Fyn to TCR-z in NOD versus
control thymocytes. Phosphopeptide mapping studies re-
vealed that the high basal activity of Fyn in quiescent NOD
thymocytes is attributable to the dephosphorylation of Fyn
at its Tyr528 autoregulatory site. Thus, increased Fyn activ-
ity may play a major role in the induction of NOD thy-
mocyte hyporesponsiveness.
This suggested role of increased Fyn activity in T cell
hyporesponsiveness is consistent with the following obser-
vations. First, in mice homozygous for the lpr and gld muta-
tions, TCR stimulation of hyporesponsive peripheral T
lymphocytes elicits increased Fyn activity and the constitu-
tive tyrosine hyperphosphorylation of TCR-z as well as
other components of the TCR–CD3 complex (40, 41).
Second, in Th1 cells, an increase in Fyn activity correlates
Figure 5. (A) Cbl tyrosine
phosphorylation in NOD and
control thymocytes after TCR-b
or TCR-b–CD4 stimulation.
Cbl was immunoprecipitated
from precleared postnuclear ly-
sates of NOD, B6, and B/c thy-
mocytes (2 3 107 cell equiva-
lents/sample). Samples were
either unstimulated (None) or
stimulated for 1.5 min with the
indicated mAb. After resolution
by SDS-PAGE under reducing
conditions, proteins were trans-
ferred onto nitrocellulose and
immunoblotted with anti–p-Tyr. Stripping and reprobing the blot with anti-Cbl Abs confirmed that an equivalent amount of protein was loaded in each
lane. The results shown are representative of one of two separate reproducible experiments. (B) NOD and control thymocyte RIPA lysates were assayed
for Fyn-mediated Cbl tyrosine phosphorylation in cold in vitro immune complex kinase assays. Cbl was immunoprecipitated from precleared postnuclear
RIPA fractions of unstimulated thymocyte lysates, and was used as a substrate for Fyn. Kinase assay samples were resolved on SDS-PAGE under reducing
conditions, transferred to nitrocellulose, and immunoblotted with an anti–p-Tyr mAb.895 Salojin et al.
with the induction of anergy (42, 43), suggesting that these
changes in Fyn activity play a crucial role in maintaining
hyporesponsiveness to antigen. Third, we recently found
that increased Fyn activity is not mediated by Lck in acti-
vated NOD thymocytes (Zhang, J., K. Salojin, and T.L.
Delovitch, manuscript submitted for publication). There-
fore, it is conceivable that the increased activity of Fyn in
hyporesponsive T cells is due to a deficiency in its tyrosine
dephosphorylation. Analyses of the activity of several pro-
tein tyrosine phosphatases in NOD thymocytes are re-
quired to explore this possibility.
Interestingly, TCR-b–CD4 stimulation induces an in-
creased binding of TCR-associated phospho-Fyn to TCR-z
in NOD thymocytes. This may give rise to the impaired
recruitment of ZAP70 to membrane-bound TCR-z and
the deficient phosphorylation of TCR-z–associated ZAP70
observed in NOD thymocytes. Thus, the increased associa-
tion of Fyn with TCR-z may represent an important early
TCR-induced event of an anergic response in T cells.
Our observation that the Fyn–TCR-z–Cbl signaling
pathway is differentially activated in TCR-stimulated NOD
T cells may also explain how increased Fyn activity con-
tributes to the induction of hyporesponsiveness in NOD T
cells. Fyn preferentially interacts with Cbl in T cells (35,
36), because tyrosine phosphorylated Cbl is found only in
Fyn-containing and not in Lck-containing immune com-
plexes (36; our unpublished observations). The amount of
Fyn-associated Cbl and extent of Fyn-mediated tyrosine
phosphorylation of Cbl are generally enhanced upon TCR
cross-linking (35). In this regard, we found that TCR
cross-linking significantly augments the tyrosine phosphor-
ylation of Cbl by Fyn in NOD thymocytes relative to con-
trol thymocytes. These findings may have important impli-
cations since overexpression of Cbl blocks Syk activity,
Syk–Fc receptor interactions and intracellular signaling in
rat basophils (37), and the Cbl homologue sli-1 functions as
a negative regulator of the Let-23 receptor PTK pathway
of activation that involves Grb2 and Ras homologues in
Caenorhabditis elegans (44). Thus, elevated and/or altered
Fyn–TCR-z–Cbl interactions may disrupt downstream
ZAP70–Grb2–Ras activation and signaling in T cells. Fur-
ther studies are required to elucidate the mechanism and
physiological role of differential activation of the Fyn–
TCR-z–Cbl pathway in hyporesponsive NOD thymocytes.
We thank Drs. J. Bolen, A. Veillette, L. Samelson, D. Motto, and G. Koretsky for their kind gifts of re-
agents; S. Rowland and C. Richardson for maintaining our mouse colony; all members of our laboratory for
their valuable advice and encouragement; and Dr. J. Madrenas for his critical evaluation of the manuscript.
We also thank Ms. A. Leaist for her expert assistance with the preparation of this manuscript.
This work was supported by grants from the Juvenile Diabetes Foundation International, a Medical Re-
search Council of Canada/Juvenile Diabetes Foundation International Diabetes Interdisciplinary Research
Program, and the Helen M. Armstrong grant from the Canadian Diabetes Association. K. Salojin, J. Zhang,
and B. Gill were recipients of Juvenile Diabetes Foundation International postdoctoral fellowships, and G.
Arreaza was the recipient of a Canadian Diabetes Association postdoctoral fellowship.
Address correspondence to Dr. T.L. Delovitch, Director, Autoimmunity/Diabetes Group, The John P.
Robarts Research Institute, 1400 Western Road, London, Ontario N6G 2V4, Canada. Phone: 519-663-
3972; FAX: 519-663-3847; E-mail: del@rri.on.ca
Received for publication 11 April 1997 and in revised form 10 July 1997.
References
1. Schwartz, R.H. 1996. Models of T cell anergy: is there a
common molecular mechanism?. J. Exp. Med. 184:1–8.
2. Jaramillo, A., B.M. Gill, and T.L. Delovitch. 1994. The
NOD mouse: a model of autoimmune type I diabetes.  Life
Sci. 55:1163–1177.
3. Zipris, D., A.H. Lazarus, A.R. Crow, M. Hadzija, and T.L.
Delovitch. 1991. Defective thymic T cell activation by con-
canavalin A and anti-CD3 in autoimmune nonobese diabetic
mice. Evidence for thymic T cell anergy that correlates with
the onset of insulitis. J. Immunol. 146:3763–3771.
4. Serreze, D.V., H.R. Gaskins, and E.H. Leiter. 1993. Defects
in the differentiation and function of antigen presenting cells
in NOD/Lt mice. J. Immunol. 150:2534–2543.
5. Hanson, M.S., M. Cetkovic-Cvrlje, V.K. Ramiya, M.A. At-
kinson, N.K. Maclaren, B. Singh, J.F. Elliott, D.V. Serreze,
and E.H. Leiter. 1996. Quantitative thresholds of MHC class
II I-E expressed on hemopoietically derived antigen-present-
ing cells in transgenic NOD/Lt mice determine level of dia-
betes resistance and indicate mechanism of protection. J. Im-
munol. 157:1279–1287.
6. Zipris, D., A.R. Crow, and T.L. Delovitch. 1991. Altered
thymic and peripheral T-lymphocyte repertoire preceding
onset of diabetes in NOD mice. Diabetes. 40:429–435.
7. Rapoport, M.J., E.H. Leiter, A. Jaramillo, P. Cyopick, D.
Zipris, J.S. Danska, A.H. Lazarus, T.L. Delovitch, and D.V.
Serreze. 1993. Interleukin 4 reverses T cell proliferative unre-
sponsiveness and prevents the onset of diabetes in nonobese
diabetic mice. J. Exp. Med. 178:87–99.
8. Rapoport, M., A.H. Lazarus, A. Jaramillo, E. Speck, and T.L.
Delovitch. 1993. Thymic T cell anergy in autoimmune non-
obese diabetic mice is mediated by deficient T cell receptor
regulation of the pathway of p21Ras activation. J. Exp. Med.
177:1221–1226.
9. Fields, P.E., T.F. Gajewski, and F.W. Fitch. 1996. Blocked
p21Ras activation in anergic CD41 T cells. Science (Wash.
DC). 271:1276–1278.896 Altered TCR–CD3 Phosphorylation and mSOS Activity in NOD T Cells
10. Li, W., C.D. Whaley, A. Mondino, and D.L. Mueller.
1996a. Blocked signal transduction to the ERK and JNK
protein kinases in anergic CD41 T cells. Science (Wash. DC).
271:1272–1276.
11. Karin, M., and T. Hunter. 1995. Transcriptional control by
protein phosphorylation: signal transmission from the cell
surface to the nucleus. Curr. Biol. 5:747–757.
12. Cantrell, D. 1996. T cell antigen receptor signal transduction
pathways. Annu. Rev. Immunol. 14:259–274.
13. Bonfini, L., C.A. Karlovich, C. Dasgupta, and U. Banerjee.
1992. The son of sevenless gene product: a putative activator
of Ras. Science (Wash. DC). 255:603–606.
14. Chardin, P., J.H. Camonis, N.W. Gale, and D. Bar-Sagi.
1993. Human Sos1: a guanine nucleotide exchange factor for
Ras that binds to GRB2. Science (Wash. DC). 260:1338–
1343.
15. Bowtell, D., P. Fu, M. Simon, and P. Senior. 1992. Identifi-
cation of murine homologues of the Drosophila son of seven-
less gene: potential activators of Ras. Proc. Natl. Acad. Sci.
USA. 89:6511–6518.
16. Reif, K., L. Buday, J. Downward, and D.A. Cantrell. 1994.
SH3 domains of the adapter molecule Grb2 complex with
two proteins in T cells: the guanine nucleotide exchange
protein SOS and a 75kDa protein that is a substrate of the T
cell antigen receptor activated tyrosine kinases. J. Biol. Chem.
269:14081–14089.
17. Egan, S.E., B.W. Giddings, M.W. Brooks, L. Buday, A.M.
Sizeland, and R.A. Weinberg. 1993. Association of Sos Ras
exchange protein with Grb2 is implicated in tyrosine kinase
signal transduction and transformation. Nature (Lond.). 363:
45–51.
18. Holsinger, L.J., D.M. Spencer, D. Austin, S.L. Schreiber, and
G.R. Crabtree. 1995. Signal transduction in T lymphocytes
using a conditional allele of SOS. Proc. Natl. Acad. Sci. USA.
92:9810–9814.
19. Secrist, J.P., L. Karnitz, and R.T. Abraham. 1991. T-cell an-
tigen receptor ligation induces tyrosine phosphorylation of
phospholipase C-gamma 1. J. Biol. Chem. 266:12135–12139.
20. Todderud, G., M.I. Wahl, S.G. Rhee, and G. Carpenter.
1990. Stimulation of phospholipase C-gamma 1 membrane
association by epidermal growth factor. Science (Wash. DC).
249:296–298.
21. Iwashima, M., B.A. Irving, N.S. van Oers, A.C. Chan, and
A. Weiss. 1994. Sequential interactions of the TCR with two
distinct cytoplasmic tyrosine kinases. Science (Wash. DC). 263:
1136–1139.
22. Chan, A.C., M. Iwashima, C.W. Turck, and A. Weiss. 1992.
ZAP-70: a 70 kD protein–tyrosine kinase that associates with
the TCR zeta chain. Cell. 71:649–662.
23. Wange, R.L., S.N. Malek, S. Desiderio, and L.E. Samelson.
1993. Tandem SH2 domains of ZAP-70 bind to T cell anti-
gen receptor zeta and CD3 epsilon from activated Jurkat T
cells. J. Biol. Chem. 268:19797–19801.
24. van Oers, N.S., A. Weiss, and N. Killeen. 1994. ZAP-70 is
constitutively associated with tyrosine phosphorylated TCR
zeta in murine thymocytes and lymph node T cells. Immunity.
1:675–685.
25. Nel, A., S. Gupta, L. Lee, J.A. Ledbetter, and S.B. Kanner.
1996. Ligation of the T-cell antigen receptor (TCR) induces
association of hSos1, ZAP-70, phospholipase C-g1, and
other phosphoproteins with Grb2 and the z-chain of the
TCR.  J. Biol. Chem. 270:18428–18436.
26. Sieh, M., A. Batzer, J. Schlessinger, and A. Weiss. 1994.
GRB2 and phospholipase C-gamma 1 associate with a 36- to
38-kilodalton phosphotyrosine protein after T-cell receptor
stimulation. Mol. Cell. Biol. 14:4435–4442.
27. Buday, L., S.E. Egan, P.R. Viciana, D.A. Cantrell, and J.
Downward. 1994. A complex of Grb2 adaptor protein, Sos
exchange factor, and a 36-kDa membrane-bound tyrosine
phosphoprotein is implicated in Ras activation in T cells. J.
Biol. Chem. 269:9019–9023.
28. Fukazawa, T., K.A. Reedquist, G. Panchamoorthy, S. Sol-
toff, T. Trub, B. Druker, L. Cantley, S.E. Shoelson, and H.
Band. 1995. T cell activation-dependent association between
the p85 subunit of the phosphatidylinositol 3-kinase and
Grb2/phospholipase Cg1-binding phosphotyrosyl protein
pp36–38.  J. Biol. Chem. 270:20177–20182.
29. Boussiotis, V.A., D.L. Barber, B.J. Lee, J.G. Gribben, G.J.
Freeman, and L.M. Nadler. 1996. Differential association of
protein tyrosine kinases with the T cell receptor is linked to
the induction of anergy and its prevention by B7 family–
mediated costimulation. J. Exp. Med. 184:365–376.
30. Luo, K., T.R. Hurley, and B.M. Sefton. 1991. Cyanogen
bromide cleavage and proteolytic peptide mapping of pro-
teins immobilized to membranes. In Methods in Enzymol-
ogy. Vol. 201. T. Hunter and B.M. Sefton, editors. Aca-
demic Press, Inc., San Diego, CA. 149–152.
31. Langlois, W.J., J. Medh, J.W. Leitner, T. Sasaoka, J.M. Olef-
sky, and B. Draznin. 1994. Insulin and epidermal growth fac-
tor influence guanine nucleotide-releasing factor by distinct
mechanisms. Endocrinology. 135:2412–2417.
32. Rozdzial, M.M., B. Malissen, and T.H. Finkel. 1995. Ty-
rosine-phosphorylated T cell receptor z chain associates with
the actin cytoskeleton upon activation of mature T lympho-
cytes. Immunity. 3:623–633.
33. Migita, K., and A. Ochi. 1994. Induction of clonal anergy by
oral administration of staphylococcal enterotoxin B. Eur. J.
Immunol. 24:2081–2086.
34. Quill, H., M.P. Riley, E.A. Cho, J.E. Casnellie, J.E. Reed,
and T. Torigoe. 1992. Anergic Th1 cells express altered lev-
els of the protein tyrosine kinases lck and p59fyn. J. Immunol.
149:2887–2893.
35. Fukazawa, T., K.A. Reedquist, T. Trub, S. Soltoff, G. Pan-
chamoorthy, B. Druker, L. Cantley, S.E. Shoelson, and H.
Band. 1995. The SH3 domain-binding T cell tyrosyl phos-
phoprotein p120. Demonstration of its identity with the
c-cbl protooncogene product and in vivo complexes with
Fyn, Grb2, and phosphatidylinositol 3-kinase. J. Biol. Chem.
270:19141–19150.
36. Tsygankov, A.Y., S. Mahajan, J. Fincke, and J.B. Bolen.
1996. Specific association of tyrosine-phosphorylated c-cbl
with Fyn tyrosine kinase in T cells. J. Biol. Chem. 271:27130–
27137.
37. Ota, Y., and L.E. Samelson. 1997. The product of the proto-
oncogene c-cbl: a negative regulator of the Syk tyrosine ki-
nase. Science (Wash. DC). 276:418–420.
38. Holt, K.H., S.B. Waters, S. Okada, K. Yamauchi, S.J.
Decker, A.R. Altiel, D.G. Motto, G.A. Koretzky, and J.E.
Pessin. 1996. Epidermal growth factor receptor targeting pre-
vents uncoupling of the Grb2–SOS complex. J. Biol. Chem.
271:8300–8306.
39. Tridandapani, S., G.W. Chacko, J.R. Van Brocklyn, and
K.M. Coggeshall. 1997. Negative signaling in B cells causes
reduced Ras activity by reducing Shc–Grb2 interactions. J.
Immunol. 158:1125–1132.
40. Katagiri, T., J.P.-Y. Ting, R. Dy, C. Prokop, P. Cohen, and897 Salojin et al.
S. Earp. 1989. Tyrosine phosphorylation of a c-src–like pro-
tein is increased in membranes of CD42CD82 T lympho-
cytes from lpr/lpr mice. Mol. Cell. Biol. 9:4914–4922.
41. Altman, A. 1994. Abnormal antigen receptor–initiated signal
transduction in lpr T lymphocytes. Semin. Immunol. 6:9–17.
42. Gajewski, T.F., P. Fields, and F.W. Fitch. 1995. Induction of
the increased Fyn activity in anergic T helper type 1 clones
requires calcium and protein synthesis and is sensitive to cy-
closporin A. Eur. J. Immunol. 25:1836–1842.
43. Gajewski, T.F., D. Qia, P. Fields, and F.W. Fitch. 1994. An-
ergic T-lymphocyte clones have altered inositol phosphate,
calcium, and tyrosine kinase signaling pathways. Proc. Natl.
Acad. Sci. USA. 91:38–42.
44. Yoon, C.H., J. Lee, G.D. Jongeward, and P. Sternberg.
1995. Similarity of sli-1, a regulator of vulval development in
C. elegans, to the mammalian proto-oncogene c-Cbl. Science
(Wash. DC). 269:1102–1105.